Company / Operating Income
Insulet Corporation Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$473.8M
FY2025
5-year range
$37.6M / $473.8M
FY2021-FY2025
Trend
+53.4%
vs FY2024
Sector context
#41 of 151
Health Care
What the data says
At $474M, Insulet Corporation's operating income ranks #41 of 151 in the Health Care sector. Operating Income has increased for 3 consecutive years, from $38M in FY2022 to $474M in FY2025.
Based on SEC 10-K filings.
$474M in FY2025 with a 5-year CAGR of +55.9%.
Improved from $220M to $474M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- +132.7%
- 5-Year CAGR
- +55.9%
- 10-Year CAGR
- -
Sector benchmark
#41 of 151 in Health CareTop 27% of 151This company $473.8M Sector average $716.7M
▼
-33.9% below sector average
Key checks
Key Insights
- Insulet Corporation's operating income has grown for 3 consecutive years.
- 5-year CAGR of +55.9%, indicating consistent growth.
- In FY2025, operating income increased 53.4% year-over-year.
- Ranks #41 out of 151 companies in the Health Care sector.
Company context
Key Data Points
- Strong profit margin: 20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $473.8M | +53.4% |
| FY2024 | $308.9M | +40.3% |
| FY2023 | $220.1M | +485.4% |
| FY2022 | $37.6M | -70.2% |
| FY2021 | $126.0M | +144.7% |
| FY2020 | $51.5M | +3.0% |
| FY2019 | $50.0M | +82.5% |
| FY2018 | $27.4M | +470.3% |
| FY2017 | -$7.4M | +30.9% |
| FY2016 | -$10.7M | +78.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026